Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Genes and Immunity|February 24, 2001
Lack of association between the interferon regulatory factor-1 (IRF1) locus at 5q31.1 and multiple sclerosis in Germany, northern Italy, Sardinia and SwedenK Vandenbroeck, C Hardt, J Louage, et al.Neurology|June 17, 1999
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patientsF L Sciacca, C Ferri, K Vandenbroeck, et al.Genes and Immunity|September 24, 2010
Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infectionK Vandenbroeck, I Alloza, B Swaminathan, et al.Genes and Immunity|January 28, 2005
IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosisO H Kantarci, A Goris, D D Hebrink, et al.Genes and Immunity|July 1, 2011
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosisK Vandenbroeck, J Alvarez, B Swaminathan, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosisE Cantó, F Reverter, C Morcillo-Suárez, et al.Genes and Immunity|December 2, 2011
ANKRD55 and DHCR7 are novel multiple sclerosis risk lociI Alloza, D Otaegui, A Lopez de Lapuente, et al.Genes and Immunity|October 15, 2010
Replication of top markers of a genome-wide association study in multiple sclerosis in SpainM L Cavanillas, O Fernández, M Comabella, et al.Genes and Immunity|May 29, 2010
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosisA Alcina, K Vandenbroeck, D Otaegui, et al.The Pharmacogenomics Journal|March 23, 2016
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association studyS Mahurkar, M Moldovan, V Suppiah, et al.Pageof 5